scispace - formally typeset
P

Prashant Patel

Researcher at University of Birmingham

Publications -  95
Citations -  2886

Prashant Patel is an academic researcher from University of Birmingham. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 18, co-authored 79 publications receiving 2091 citations. Previous affiliations of Prashant Patel include National Chemical Laboratory & Google.

Papers
More filters
Journal ArticleDOI

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, +798 more
- 27 Oct 2018 - 
TL;DR: In patients with type 2 diabetes and cardiovascular disease, albiglutide was superior to placebo with respect to major adverse cardiovascular events, and evidence-based glucagon-like peptide 1 receptor agonists should be considered as part of a comprehensive strategy to reduce the risk of cardiovascular events.
Journal ArticleDOI

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

Martin R. Gaudinski, +89 more
- 05 Dec 2017 - 
TL;DR: Both DNA vaccines expressing premembrane and envelope Zika virus structural proteins were safe and well tolerated and followed up volunteers for 24 months for safety and immunogenicity, respectively.
Journal ArticleDOI

Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes.

Aneel Bhangu, +78 more
TL;DR: The aim of the Beyond TME Group was to achieve consensus on the definitions and principles of management, and to identify areas of research priority.
Journal ArticleDOI

Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial

TL;DR: The initial results do not support routine administration of adjuvant radiotherapy after radical prostatectomy, and an observation policy with salvage radiotherapy for PSA biochemical progression should be the current standard after radical Prostate cancer.
Journal ArticleDOI

Synthesis of silver nanoparticles by sophorolipids: Effect of temperature and sophorolipid structure on the size of particles

TL;DR: In this article, the authors reported in situ synthesis of silver nanoparticles using biosurfactants called sophorolipids as reducing and capping agents, and further studied the effect of temperature and the structure of sophoroline on the size of the resulting nanoparticles.